DDIT4 and neoplasm: The DDIT4 and DKK1 anti-senescence genes were upregulated in SAOS2 cells in the presence of DNA damage when compared to p53 positive U2OS cells (Table S11 in File S1), marking them as potential drug development targets for chemotherapy of p53 negative tumours.